Win Next Year's Screening Contract Before Anyone Puts It Out to Tender

It renews on a date, so it is lost on a date

A company that screened its staff last September will screen them again this September. It will do it with you, or with whichever laboratory started the conversation in July. Nothing about that outcome is decided by clinical quality; it is decided by whether anyone reopened the account while there was still time. Screening revenue is rarely lost in a competitive pitch. It is lost by default.

Hold the employer, not just the participants

The unit that matters is the company: headcount, package tier, screening window and renewal month. Held that way, the account can carry a task that fires before the anniversary, and last cycle's participation becomes a comparison rather than a memory. An employer that brought three hundred staff last year and ninety this year has told you something specific, and hearing it from your own pipeline is considerably better than hearing it from the year-end report.

Under-registration happens in the quiet week beforehand

On-site screening days fail in predictable ways. Registration is slow in the week before and nobody notices until the morning. Stations are staffed for the headcount rather than for the arrival pattern, so a queue forms at nine and the room is empty at two. Both are visible in advance if the day is planned as an event with capacity and a participant list rather than as a date in a calendar.

The follow-up afterwards is where the value is

The most important part of a screening programme happens after everyone has gone back to work: the participants whose results warrant a repeat test or a referral. Handled through the report alone, a meaningful number of those never close the loop. Treating each one as a task with an owner turns a screening event from a volume exercise into something the employer can see the point of renewing.

Volume from a clinic is a trend

Outside the corporate stream, general practice and specialist clinics send the work. The useful signal is not how many episodes a clinic sent but whether that number is moving. A clinic quietly splitting its work between two laboratories looks exactly like a loyal clinic until you compare quarters.

Small geography, real coverage discipline

Singapore is compact enough that visiting referring clinics is genuinely feasible, which makes the absence of a coverage record harder to justify. Logging each visit against the clinic shows who has been seen this quarter and who has been skipped, and it survives the person covering the territory changing role.

Clinical reminders and marketing are separate categories

Local rules on marketing messages to Singapore numbers, and on the handling of personal data generally, mean the difference between a clinical reminder and a promotional offer should be a decision your organisation has already made rather than one taken per campaign. Recording the consent basis and contact preference on the patient record, and logging every message that goes out, turns a later question into a lookup.

Register the language, then stop thinking about it

A patient population that is not uniformly English-first does not need parallel processes. It needs language as a field on the record and a template per language, so the reminder goes out correctly without anyone deciding on the day. The share of reminders that are actually read is the metric that moves.

Licensing and data protection stay with you

Your licence to operate and your obligations over personal data belong to the laboratory, not to a software vendor, and any system holding identifiable patient information falls inside them. What a CRM adds is evidence — timestamped contact history, visible record changes, access limited by role — with clinical results left in the LIS. Agree the minimum set of identifiers the commercial system needs with your data protection officer before the first import.